Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor

Biochemical Pharmacology

Volumn 69, Issue 4, 2005, Pages 603-616

  Sasakawa, Yuka ^a   Naoe, Yoshinori ^a   Sogo, Naoki ^a   Inoue, Takeshi ^a   Sasakawa, Tatsuya ^a   Matsuo, Masahiko ^a   Manda, Toshitaka ^a   Mutoh, Seitaro ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Caspase 9; FK228; FR901228; GeneChip; Histone deacetylase inhibitor; MKP 1

Indexed keywords

CASPASE 9; CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR 1; FR 901228; HISTONE DEACETYLASE INHIBITOR; HISTONE H1; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; MALE; MARKER GENE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; UPREGULATION;

ANIMALS; CASPASE 9; CASPASES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DEPSIPEPTIDES; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; IMMEDIATE-EARLY PROTEINS; MALE; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; TIME FACTORS;

EID: 12744251611     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.11.008     Document Type: Article

References (44)

1. H. Ueda, H. Nakajima, Y. Hori, T. Fujita, M. Nishimura, and T. Goto FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity J Antibiot (Tokyo) 47 1994 301 310
2. N. Shigematsu, H. Ueda, S. Takase, H. Tanaka, K. Yamamoto, and T. Tada FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968. II. Structure determination J Antibiot (Tokyo) 47 1994 311 314
3. H. Ueda, T. Manda, S. Matsumoto, S. Mukumoto, F. Nishigaki, and I. Kawamura FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968. III. Antitumor activities on experimental tumors in mice J Antibiot (Tokyo) 47 1994 315 323
4. G. Rajgolikar, K.K. Chan, and H.C. Wang Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells Breast Cancer Res Treat 51 1998 29 38
5. H. Nakajima, Y.B. Kim, H. Terano, M. Yoshida, and S. Horinouchi FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor Exp Cell Res 241 1998 126 133
6. M. Grunstein Histone acetylation in chromatin structure and transcription Nature 389 1997 349 352
7. B.M. Turner Decoding the nucleosome Cell 75 1993 5 8
8. Y. Sasakawa, Y. Naoe, T. Inoue, T. Sasakawa, M. Matsuo, and T. Manda Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo Biochem Pharmacol 64 2002 1079 1090
9. M. Yoshida, M. Kijima, M. Akita, and T. Beppu Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A J Biol Chem 265 1990 17174 17179
10. A. Saito, T. Yamashita, Y. Mariko, Y. Nosaka, K. Tsuchiya, and T. Ando A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors Proc Natl Acad Sci USA 96 1999 4592 4597
11. V.M. Richon, S. Emiliani, E. Verdin, Y. Webb, R. Breslow, and R.A. Rifkind A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases Proc Natl Acad Sci USA 95 1998 3003 3007
12. C. Van Lint, S. Emiliani, and E. Verdin The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation Gene Expr 5 1996 245 253
13. Y. Sasakawa, Y. Naoe, T. Inoue, T. Sasakawa, M. Matsuo, and T. Manda Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo Cancer Lett 195 2003 161 168
14. H. Kosugi, M. Towatari, S. Hatano, K. Kitamura, H. Kiyoi, and T. Kinoshita Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy Leukemia 13 1999 1316 1324
15. P.J. Higgins, and M.P. Ryan p52(PAI-1) and actin expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells Biochem J 279 1991 883 890
16. V.M. Richon, T.W. Sandhoff, R.A. Rifkind, and P.A. Marks Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation Proc Natl Acad Sci USA 97 2000 10014 10019
17. B.P. Ashburner, S.D. Westerheide, and A.S. Baldwin Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol Cell Biol 21 2001 7065 7077
18. M. Fournel, M.C. Trachy-Bourget, P.T. Yan, A. Kalita, C. Bonfils, and C. Beaulieu Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors Cancer Res 62 2002 4325 4330
19. L.C. Sambucetti, D.D. Fischer, S. Zabludoff, P.O. Kwon, H. Chamberlin, and N. Trogani Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects J Biol Chem 274 1999 34940 34947
20. T.G. Sourlingas, D.S. Tsapali, A.D. Kaldis, and E. Sekeri-Pataryas Histone deacetylase inhibitors induce apoptosis in peripheral blood lymphocytes along with histone H4 acetylation and the expression of the linker histone variant, H1 degrees Eur J Cell Biol 80 2001 726 732
21. M.Y. Yang, T.C. Liu, J.G. Chang, P.M. Lin, and S.F. Lin JunB gene expression is inactivated by methylation in chronic myeloid leukemia Blood 101 2003 3205 3211
22. B.S. Pace, X.H. Qian, J. Sangerman, S.F. Ofori-Acquah, B.S. Baliga, and J. Han p38 MAP kinase activation mediates gamma-globin gene induction in erythroid progenitors Exp Hematol 31 2003 1089 1096
23. C. Yu, M. Rahmani, D. Conrad, M. Subler, P. Dent, and S. Grant The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571 Blood 102 2003 3765 3774
24. D.D. Yang, C.Y. Kuan, A.J. Whitmarsh, M. Rincon, T.S. Zheng, and R.J. Davis Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene Nature 389 1997 865 870
25. M.M. McLaughlin, S. Kumar, P.C. McDonnell, S. Van Horn, J.C. Lee, and G.P. Livi Identification of mi togen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase J Biol Chem 271 1996 8488 8492
26. H.J. Shin, K.H. Baek, A.H. Jeon, S.J. Kim, K.L. Jang, and Y.C. Sung Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation Oncogene 22 2003 3853 3858
27. M. Inaba, T. Tashiro, T. Kobayashi, Y. Sakurai, K. Maruo, and Y. Ohnishi Responsiveness of human gastric tumors implanted in nude mice to clinically equivalent doses of various antitumor agents Jpn J Cancer Res 79 1988 517 522
28. T. Tashiro, M. Inaba, T. Kobayashi, Y. Sakurai, K. Maruo, and Y. Ohnishi Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses Cancer Chemother Pharmacol 24 1989 187 192
29. K. Kuida Caspase-9 Int J Biochem Cell Biol 32 2000 121 124
30. N. Shinoura, S. Sakurai, A. Asai, T. Kirino, and H. Hamada Transduction of Apaf-1 or caspase-9 induces apoptosis in A-172 cells that are resistant to p53-mediated apoptosis Biochem Biophys Res Commun 272 2000 667 673
31. P.S. Schwartz, and D.J. Waxman Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells Mol Pharmacol 60 2001 1268 1279
32. L.A. Sitailo, S.S. Tibudan, and M.F. Denning Activation of caspase-9 is required for UV-induced apoptosis of human keratinocytes J Biol Chem 277 2002 19346 19352
33. R. Hakem, A. Hakem, G.S. Duncan, J.T. Henderson, M. Woo, and M.S. Soengas Differential requirement for caspase 9 in apoptotic pathways in vivo Cell 94 1998 339 352
34. C. Henderson, M. Mizzau, G. Paroni, R. Maestro, C. Schneider, and C. Brancolini Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA) J Biol Chem 278 2003 12579 12589
35. M. Camps, A. Nichols, and S. Arkinstall Dual specificity phosphatases: a gene family for control of MAP kinase function FASEB J 14 2000 6 16
36. H. Sun, C.H. Charles, L.F. Lau, and N.K. Tonks MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo Cell 75 1993 487 493
37. J. Li, M. Gorospe, D. Hutter, J. Barnes, S.M. Keyse, and Y. Liu Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation Mol Cell Biol 21 2001 8213 8224
38. J. DeRisi, L. Penland, P.O. Brown, M.L. Bittner, P.S. Meltzer, and M. Ray Use of a cDNA microarray to analyse gene expression patterns in human cancer Nat Genet 14 1996 457 460
39. O. Ermolaeva, M. Rastogi, K.D. Pruitt, G.D. Schuler, M.L. Bittner, and Y. Chen Data management and analysis for gene expression arrays Nat Genet 20 1998 19 23
40. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
41. C. Kihara, T. Tsunoda, T. Tanaka, H. Yamana, Y. Furukawa, and K. Ono Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles Cancer Res 61 2001 6474 6479
42. T.R. Golub, D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, and J.P. Mesirov Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 286 1999 531 537
43. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, and A. Rosenwald Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
44. U. Scherf, D.T. Ross, M. Waltham, L.H. Smith, J.K. Lee, and L. Tanabe A gene expression database for the molecular pharmacology of cancer Nat Genet 24 2000 236 244